Pharmacokinetic evaluation of three oral formulations of docetaxel boosted with ritonavir: two single-drug formulations vs. a fixed-dose combination tablet-Reference-Cited by-同舟云学术

Pharmacokinetic evaluation of three oral formulations of docetaxel boosted with ritonavir: two single-drug formulations vs. a fixed-dose combination tablet

Published:2013-01-11 Issue:3 Volume:3 Page:243-251
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Moes Johannes J.,Stuurman Frederik E.,Hendrikx Jeroen J.M.A.,Marchetti Serena,Huitema Alwin D.R.,Beijnen Jos H.,Schellens Jan H.M.,Nuijen Bastiaan

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1007/s13346-012-0127-6.pdf

Reference28 articles.

1. Aventis Pharma S.A. Annex I - Summary of product characteristics. In: Taxotere (r): EPAR - Product Information. European Medicines Agency. 2012. http://www.emea.europa.eu/docs/en_GB/document_library/EPAR-Product_Information/human/000073/WC500035264.pdf . Accessed 26 Dec 2012.

2. Bruno R, Hille D, Riva A, Vivier N, Ten Bokkel Huinink WW, van Oosterom AT, Kaye SB, Verweij J, Fossella FV, Valero V, Rigas JR, Seidman AD, Chevallier B, Fumoleau P, Burris HA, Ravdin PM, Sheiner LB. Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer. J Clin Oncol. 1998;1:187–96.

3. Engels FK, Sparreboom A, Mathôt RA, Verweij J. Potential for improvement of docetaxel-based chemotherapy: a pharmacological review. Br J Cancer. 2005;2:173–7.

4. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;3:413–20.

5. Gao K, Sun J, Liu K, Liu X, He Z. Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel. Drug Dev Ind Pharm. 2008;11:1227–37.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multiscale approach to targeted docetaxel formulations: combination therapy, nanotechnology, electrospinning and 3D printing—a review;Bulletin of the National Research Centre;2022-06-04

2. Enhancement of Docetaxel Absorption Using Ritonavir in an Oral Milk-Based Formulation;Pharmaceutical Research;2021-08

3. Quantification of the pharmacokinetic-toxicodynamic relationship of oral docetaxel co-administered with ritonavir;Investigational New Drugs;2020-04-19

4. A Population Pharmacokinetic Model of Oral Docetaxel Coadministered With Ritonavir to Support Early Clinical Development;The Journal of Clinical Pharmacology;2019-10-09

5. Pharmaceutical development of an oral tablet formulation containing a spray dried amorphous solid dispersion of docetaxel or paclitaxel;International Journal of Pharmaceutics;2016-09